Comparing Surgery Followed by IVF Versus IVF Alone in Women Under 39 with Advanced Endometriosis and Infertility
A National Multicenter Randomized Trial Evaluating Live Birth Outcomes
Led by Karolinska Institutet · Updated on 2025-11-20
350
Participants Needed
4
Research Sites
156 weeks
Total Duration
AI-Summary
What this Trial Is About
Endometriosis is a chronic condition affecting about 10% of women of reproductive age, often causing pelvic pain and infertility. Women with advanced endometriosis stage III-IV have significantly reduced fertility compared to the general population. This study is the first national multicenter randomized controlled trial comparing surgery followed by IVF with IVF alone to determine which approach better improves pregnancy outcomes in women with advanced endometriosis and infertility.
Participants are women under 39 years with stage III-IV endometriosis seeking fertility treatment. They will be randomly assigned to either first undergo laparoscopic surgery to remove endometriosis lesions followed by IVF or to proceed directly to IVF without surgery. Surgery will be performed at specialized centers using laparoscopic techniques, while IVF treatment will involve up to three cycles of controlled ovarian stimulation and embryo transfers according to routine clinical protocols.
During the study, participants will undergo ultrasound and possibly MRI to confirm endometriosis staging. Researchers will monitor pregnancy rates, live birth rates within three years, time to pregnancy, treatment complications, and quality of life using questionnaires. Data on healthcare costs and safety outcomes will also be collected. Long-term follow-up at ten years will assess fertility treatments, live births, and repeat surgeries. The total study duration for each participant is three years from first treatment.
CONDITIONS
Brief Title
First Line Surgery or First Line Fertility Treatment Using Assisted Reproductive Technologies in Patients With Advanced Endometriosis
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosed with endometriosis stage III-IV according to AAGL classification
Eligible for assisted reproductive technology treatments such as IVF or ICSI
Body mass index between 18 and 35 kg/m2
Signed an approved informed consent form
You will not qualify if you...
Previous surgery for endometriosis except diagnostic laparoscopy
Previous IVF or ICSI cycles including fertility preservation
Presence of hemato- or hydrosalpinx
Clear indication for surgery such as ureteral stenosis or intestinal symptoms
Suspicion of malignancy
Submucosal fibroids (FIGO 0-1, any size) or intramural fibroids larger than 4 cm (FIGO 2-5)
Uterine malformations (class U1-U6 according to ESHRE/ESGE classification)
Contraindications to surgery
Undergoing ART with donated oocytes
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 6 months from randomization to first treatment, followed by treatment cycles as clinically indicated
Participants receive either first-line surgery followed by assisted reproductive technologies (ART) such as IVF or ICSI, or first-line ART treatment alone with up to three cycles of controlled ovarian stimulation, oocyte retrievals, and embryo transfers according to routine clinical protocols.
Multiple visits including surgery and up to three ART cycles with oocyte retrieval and embryo transfer visits
Follow-up
Duration - Up to 3 years after first treatment
Participants are followed for reproductive outcomes, quality of life, pain assessment, complications, and health economics for up to three years after first treatment.
Scheduled visits before treatment, at oocyte retrieval, 2 months after ART or surgery, and periodic follow-up visits including a 3-year follow-up visit
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Large Prospective Study on Environmental and Lifestyle Effects on Infertility and Assisted Reproductive Technology Success
Phase 2 Study of Two Vipoglanstat Doses to Treat Moderate to Severe Endometriosis Pain in Women Aged 18 to 44
Long-Term Study of Relugolix Combination Tablet to Monitor Bone Health in Premenopausal Women With Heavy Menstrual Bleeding From Fibroids or Pain From Endometriosis
Study of the Aurora Test for Selecting Day 5 Embryos in ICSI Treatment
Assessing Impact on Pregnancy and Live Birth Rates in Women Undergoing IVFICSI
A Randomized Controlled Study Testing a Whole Food Plant-Based Diet for Women Aged 18-45 With Endometriosis to Improve Pain and Quality of Life
Investigating the Link Between Endometriosis and Tissue Microbiota in Women Aged 18 to 52
Comparing Argon Plasma Device to Standard Surgery for Treating Ovarian Endometrioma in Women Aged 18 to 40
Evaluating a New High-CBD Treatment for Gynecologic Pain from Endometriosis, Adenomyosis, or PID
Evaluating GnRH Agonist Injections Before Frozen Embryo Transfer
for Women With Endometriosis andor Adenomyosis
Study of Telomere and Biological Aging Markers to Guide Personalized Traditional Chinese and Conventional Medicine Treatment in Women With Persistent Unexplained Infertility After Prior Treatments
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Endo-SOFT: study protocol for a national multicentre randomised controlled trial - first-line surgery versus first-line assisted reproductive technologies in patients with advanced endometriosis.
Anna Marklund, Julia Wängberg Nordborg, Christine Asciutto...